Hyperlipidemias
167
13
20
113
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
23 trials with published results (14%)
Research Maturity
113 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.4%
4 terminated out of 167 trials
96.6%
+10.1% vs benchmark
12%
20 trials in Phase 3/4
20%
23 of 113 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 113 completed trials
Clinical Trials (167)
A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
Lipid Management in Renal Transplant Recipients Using Evolocumab.
Penn Medicine Healthy Heart
Imaging the Pathogenesis of Cerebral Small Vessel Disease
A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia
Centralized Prescribing for Statins
Biological Sample Repository for Gastrointestinal Disorders
Social Needs Screening and Chronic Diseases Study (WE CARE)
Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
Virtual Diabetes Group Visits Across Health Systems
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
The Role of Proprotein-convertase-subtilisin/Kexin-type 9 in Kidney Damage in Nephrotic Syndrom
Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination
Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population
Effect of ANKASCIN 568-P Products Regulating Blood Lipid
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness